US FDA lifts warning letter issued to USV’s Daman facility
The company expects seven ANDA approvals in the near future and are expecting a 40-50 growth in our US business over the next two…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Biocon gets six observations from US FDA for Malaysia facility
The company, however, did not share the details of the observations made by the US Food and Drug Administration
AstraZeneca’s immunotherapy drug wins key lung cancer approval
The approval was based on a trial involving 713 patients
Ravi Prakash Bhagavathula, Chief Financial Officer, Pfizer resigns
He will pursue opportunities outside Pfizer
Suven gets product patents from India, South Korea
The patents are valid through 2029 and 2033
HC restrains ex-Ranbaxy promoters from selling assets till Feb 26
The court also directed the brothers and 12 others, including their family members and companies, to come up with a plan on how…
DRL’s Chairman, COO added as defendants in US lawsuit
The lawsuit filed at the District Court for New Jersey seeks damages to compensate the class of investors for a 'purported…
NATCO Pharma undergoes API facility inspection by US FDA
The regulatory audit resulted in zero observations and no Form 483 was issued
amfAR renews investment in bioengineering approaches to curing HIV
Totalling nearly $1 million, the investment grants will allow two collaborative teams of HIV researchers and bioengineers to…
Glenmark Pharma presents new data on GBR 830
The first-in class, investigational, anti-OX40 monoclonal antibody is indicated for the treatment of moderate-to-severe atopic…
APICS, IMA release report on supply chain management
The new report offers solution to widespread costing failures
GSK receives European approval for Influenza vaccine
The drug will be able to treat both adults and children from six months of age
Mosquito gut may hold the key to preventing dengue and zika
The study describes the first comprehensive analysis of the Aedes aegypti midgut
AstraZeneca Pharma launches anti-diabetic tablet Xigduo XR
Xigduo XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
Bengaluru hosts India Pharma 2018 and India Medical Device 2018 conference
Over 20 international drug and device regulators are set to meet with Indian regulators at the venue
Union minister of Chemicals…
Queen’s University announces NDDS to reduce HIV rate
The university along with their collaborators, PATH, ViiV Healthcare, the Population Council and LTS Lohmann Therapie-Systeme will…
Govt to bring major changes in DPCO: Union Minister Ananth Kumar
Reiterates the need for a separate Ministry for Pharma and Medical Devices
GNH India clears Oman Pharmacy and Poison board audit
The audit will give preferential status to GNH India in the Oman trade market over other suppliers from countries including the US…
Sundyota Numandis in strategic alliance with Finzelberg
To exclusively represent the German phyto-pharmaceuticals major in India
Sun Pharma posts Q3FY18 results
Q3 adjusted net profit was at Rs 878 crores
Sun Pharmaceutical Industries has posted third quarter and nine month financial…